This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leong, S. P. L. Articles by Chang, J. W. C. Search for Related Content PubMed PubMed Citation Articles by Leong, S. P. L. Articles by Chang, J. W. C. Related Collections Cytokines

Cytokine Profiles of Sentinel Lymph Nodes Draining the Primary Melanoma

From the Department of Surgery, University of California at San Francisco Comprehensive Cancer Center (Mount Zion), San Francisco, California.

Correspondence: Address correspondence and reprint requests to: Stanley P. L. Leong, MD, Department of Surgery, University of California at San Francisco Comprehensive Cancer Center (Mount Zion), 1600 Divisadero St., #C333, San Francisco, CA 94143-1674; Fax: 415-353-7721; E-mail: leongs{at}surgery.ucsf.edu

Background: The sentinel lymph node (SLN) draining the primary melanoma is the first echelon node where micrometastasis is established. SLNs may be the initial sites of antigen presentation associated with immune responses.

Methods: A portion of each SLN from 68 melanoma patients undergoing selective SLN dissection was processed for enzyme-linked immunospot (ELISPOT) assay determination of interferon gamma (IFN-), interleukin-2 (IL-2), granulocyte macrophage colony-stimulating factor (GM-CSF), and interleukin-10 (IL-10) secretion. The control was the adjacent non-SLN. Lymphocytes were stimulated with staphylococcal enterotoxin A (SEA) prior to ELISPOT assay.

Results: No significant difference was noted in the production of IL-10 between the SLNs and non-SLNs. Significant production of IFN-, IL-2, and GM-CSF was noted in the SLNs when compared to the non-SLNs in the overall group. Patients with no micrometastasis (n = 60) had elevated secretion of all cytokines in the SLNs. However, patients harboring lymph node micrometastasis (n = 8) showed no increase of cytokine secretion in the SLNs.

Conclusions: Significant Th1 and Th2 response was induced in melanoma-free SLNs.

Implications: SLNs without micrometastasis may be activated by submicroscopic cells or soluble tumor antigens, while cytokine production may be down-regulated by micrometastasis. Future studies should be directed towards identifying the specific SLN T cells recognizing the tumor antigens.

Key Words: Cytokines • Sentinel lymph node • Melanoma

This article has been cited by other articles:

				S. U. Woo, J. W. Bae, J.-H. Yang, J. H. Kim, S. J. Nam, and Y. K. Shin Overexpression of Interleukin-10 in Sentinel Lymph Node with Breast Cancer Ann. Surg. Oncol., November 1, 2007; 14(11): 3268 - 3273. [Abstract] [Full Text] [PDF]

				R. J.C.L.M. Vuylsteke, B. G. Molenkamp, P. A.M. van Leeuwen, S. Meijer, P. G.J.T.B. Wijnands, J. B.A.G. Haanen, R. J. Scheper, and T. D. de Gruijl Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF-Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content. Clin. Cancer Res., May 1, 2006; 12(9): 2826 - 2833. [Abstract] [Full Text] [PDF]

				J. H. Lee, H. Torisu-Itakara, A. J. Cochran, A. Kadison, Y. Huynh, D. L. Morton, and R. Essner Quantitative Analysis of Melanoma-Induced Cytokine-Mediated Immunosuppression in Melanoma Sentinel Nodes Clin. Cancer Res., January 1, 2005; 11(1): 107 - 112. [Abstract] [Full Text] [PDF]

				G. Mariani, M. Gipponi, L. Moresco, G. Villa, M. Bartolomei, G. Mazzarol, M. C. Bagnara, A. Romanini, F. Cafiero, G. Paganelli, et al. Radioguided Sentinel Lymph Node Biopsy in Malignant Cutaneous Melanoma* J. Nucl. Med., June 1, 2002; 43(6): 811 - 827. [Abstract] [Full Text] [PDF]